Cocaine Dependence Treatment — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Psychosocial treatment without maintenance medication
Explanation lettering: B = shown as A · D = shown as B · A = shown as C · C = shown as D
C is correct. There is no licensed or NICE-recommended pharmacological maintenance treatment for cocaine dependence; psychosocial interventions are the mainstay. NICE CG51 recommends contingency management with incentives contingent on drug-negative tests (for example, cocaine-free samples) to reduce use and promote engagement, with keyworking, self-help referral and CBT reserved for comorbid mental health problems. Methadone (A) and buprenorphine (B) are opioid-substitution treatments and have no role here as he is not opioid dependent. Naltrexone (D) is for relapse prevention in selected detoxified, formerly opioid-dependent patients (and in alcohol dependence), not stimulant dependence. Acamprosate (E) is an alcohol relapse-prevention agent acting on glutamatergic transmission with no efficacy evidence in cocaine dependence. Antipsychotics may be used briefly for cocaine-induced psychosis, but that treats a complication of intoxication, not the dependence itself; here the paranoia had already resolved with abstinence.
Reference: National Institute for Health and Care Excellence. Drug misuse in over 16s: psychosocial interventions (CG51), Recommendations (contingency management for drug misuse, including cocaine). 2007, current. https://www.nice.org.uk/guidance/cg51/chapter/1-guidance